Literature DB >> 35970917

Moving beyond descriptive studies: harnessing metabolomics to elucidate the molecular mechanisms underpinning host-microbiome phenotypes.

Stephanie L Bishop1, Marija Drikic1, Soren Wacker1, Yuan Yao Chen2, Anita L Kozyrskyj2, Ian A Lewis3.   

Abstract

Advances in technology and software have radically expanded the scope of metabolomics studies and allow us to monitor a broad transect of central carbon metabolism in routine studies. These increasingly sophisticated tools have shown that many human diseases are modulated by microbial metabolism. Despite this, it remains surprisingly difficult to move beyond these statistical associations and identify the specific molecular mechanisms that link dysbiosis to the progression of human disease. This difficulty stems from both the biological intricacies of host-microbiome dynamics as well as the analytical complexities inherent to microbiome metabolism research. The primary objective of this review is to examine the experimental and computational tools that can provide insights into the molecular mechanisms at work in host-microbiome interactions and to highlight the undeveloped frontiers that are currently holding back microbiome research from fully leveraging the benefits of modern metabolomics.
© 2022. The Author(s), under exclusive licence to Society for Mucosal Immunology.

Entities:  

Year:  2022        PMID: 35970917     DOI: 10.1038/s41385-022-00553-4

Source DB:  PubMed          Journal:  Mucosal Immunol        ISSN: 1933-0219            Impact factor:   8.701


  123 in total

1.  Analysis of metabolome changes in the bile acid pool in feces and plasma of antibiotic-treated rats.

Authors:  C Behr; M Slopianka; V Haake; V Strauss; S Sperber; H Kamp; T Walk; K Beekmann; I M C M Rietjens; B van Ravenzwaay
Journal:  Toxicol Appl Pharmacol       Date:  2018-11-28       Impact factor: 4.219

Review 2.  Microbiome-Modulated Metabolites at the Interface of Host Immunity.

Authors:  Eran Blacher; Maayan Levy; Evgeny Tatirovsky; Eran Elinav
Journal:  J Immunol       Date:  2017-01-15       Impact factor: 5.422

Review 3.  The aryl hydrocarbon receptor: an environmental sensor integrating immune responses in health and disease.

Authors:  Veit Rothhammer; Francisco J Quintana
Journal:  Nat Rev Immunol       Date:  2019-03       Impact factor: 53.106

4.  Gut Microbiota in Patients With Irritable Bowel Syndrome-A Systematic Review.

Authors:  Rapat Pittayanon; Jennifer T Lau; Yuhong Yuan; Grigorios I Leontiadis; Frances Tse; Michael Surette; Paul Moayyedi
Journal:  Gastroenterology       Date:  2019-03-30       Impact factor: 22.682

Review 5.  Gut microbiota, metabolism and psychopathology: A critical review and novel perspectives.

Authors:  Robin N Groen; Nicolien C de Clercq; Max Nieuwdorp; H J Rogier Hoenders; Albert K Groen
Journal:  Crit Rev Clin Lab Sci       Date:  2018-04-20       Impact factor: 6.250

Review 6.  Interactions between the microbiota and pathogenic bacteria in the gut.

Authors:  Andreas J Bäumler; Vanessa Sperandio
Journal:  Nature       Date:  2016-07-07       Impact factor: 49.962

Review 7.  Direct and indirect effects of microbiota-derived metabolites on neuroinflammation in multiple sclerosis.

Authors:  Naomi M Fettig; Lisa C Osborne
Journal:  Microbes Infect       Date:  2021-03-26       Impact factor: 2.700

Review 8.  Introduction to the human gut microbiota.

Authors:  Elizabeth Thursby; Nathalie Juge
Journal:  Biochem J       Date:  2017-05-16       Impact factor: 3.857

9.  Colitis-Induced Microbial Perturbation Promotes Postinflammatory Visceral Hypersensitivity.

Authors:  Nicolas Esquerre; Lilian Basso; Manon Defaye; Fernando A Vicentini; Nina Cluny; Dominique Bihan; Simon A Hirota; Alana Schick; Humberto B Jijon; Ian A Lewis; Markus B Geuking; Keith A Sharkey; Christophe Altier; Yasmin Nasser
Journal:  Cell Mol Gastroenterol Hepatol       Date:  2020-04-11

Review 10.  Current understanding of the human microbiome.

Authors:  Jack A Gilbert; Martin J Blaser; J Gregory Caporaso; Janet K Jansson; Susan V Lynch; Rob Knight
Journal:  Nat Med       Date:  2018-04-10       Impact factor: 53.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.